Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | scriptaid | 4060 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | scriptaid | 4060 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | scriptaid | 4060 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | scriptaid | 4060 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | scriptaid | 4060 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | scriptaid | 4060 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | scriptaid | 4060 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | scriptaid | 4060 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | scriptaid | 4060 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | scriptaid | 4060 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | scriptaid | 4060 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | scriptaid | 4060 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfinpyrazone | 5280863 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfinpyrazone | 5280863 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfinpyrazone | 5280863 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | sulfinpyrazone | 5280863 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | sulfinpyrazone | 5280863 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sulfinpyrazone | 5280863 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfinpyrazone | 5280863 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | mebeverine | 4031 | drug-path |